Financial Metrics Check: Organon & Co (OGN)’s Ratios for Trailing Twelve Months

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

As of close of business last night, Organon & Co’s stock clocked out at $9.53, up 0.95% from its previous closing price of $9.44. In other words, the price has increased by $0.95 from its previous closing price. On the day, 3.02 million shares were traded.

Ratios:

To gain a deeper understanding of OGN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.19. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 16.52 whereas as Long-Term Debt/Eq ratio is at 16.49.

On September 06, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also upped its target price recommendation from $18 to $20.

Goldman Downgraded its Buy to Neutral on November 03, 2023, whereas the target price for the stock was revised from $33 to $16.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when COX CARRIE SMITH bought 12,469 shares for $8.07 per share. The transaction valued at 100,591 led to the insider holds 12,469 shares of the business.

Falcione Aaron bought 5,500 shares of OGN for $48,235 on May 07 ’25. The Chief Human Resources Officer now owns 62,974 shares after completing the transaction at $8.77 per share. On May 06 ’25, another insider, Weaver Kirke, who serves as the Gen. Counsel & Corp. Secy. of the company, bought 8,045 shares for $9.21 each. As a result, the insider paid 74,054 and bolstered with 52,489 shares of the company.

Valuation Measures:

As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.30, and their Forward P/E ratio for the next fiscal year is 2.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 4.54.

Stock Price History:

Over the past 52 weeks, OGN has reached a high of $23.10, while it has fallen to a 52-week low of $8.01. The 50-Day Moving Average of the stock is -12.59%, while the 200-Day Moving Average is calculated to be -38.13%.

Shares Statistics:

A total of 259.96M shares are outstanding, with a floating share count of 258.99M. Insiders hold about 0.37% of the company’s shares, while institutions hold 80.42% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.